QuantuMDx partners with Cignpost Diagnostics

QuantuMDx partners with Cignpost Diagnostics

Providing a rapid, PCR COVID-19 testing solution to the UK film & TV industry NEWCASTLE UPON TYNE, UK, 16 August 2021. QuantuMDx has announced it is partnering with Cignpost Diagnostics, (‘Cignpost’), a leading provider of COVID-19 workplace testing to the...
QuantuMDx included on PHE Microbiology Framework

QuantuMDx included on PHE Microbiology Framework

Diagnostic Goods and Services (Lot 1) Research and Development Goods (Lot 2) NEWCASTLE UPON TYNE, UK, 08 June 2021. QuantuMDx has been successful in both Public Health England (‘PHE’) tenders the Company applied for. QuantuMDx will be included in the Framework...
Mirre de Noo appointed as non-executive director

Mirre de Noo appointed as non-executive director

NEWCASTLE UPON TYNE, UK, 26 May 2021. QuantuMDx has appointed Mirre de Noo, as a Non-Executive Director. Mirre has over 20 years of experience in healthcare, strategy and innovation. As a life sciences and healthcare executive she has a track record of introducing and...
QuantuMDx completes £11m funding round

QuantuMDx completes £11m funding round

NEWCASTLE UPON TYNE, UK, 24th March 2021. QuantuMDx today announces it has raised £11 million in its latest funding round. Proceeds will be used to complete manufacturing and commercial scale up of Q-POC™, QuantuMDx’s rapid, PCR point of care diagnostic system...
Prime Minister, Boris Johnson visits QuantuMDx

Prime Minister, Boris Johnson visits QuantuMDx

NEWCASTLE UPON TYNE, UK, 13 February 2021. QuantuMDx today welcomed the Prime Minister, Rt Hon Boris Johnson MP, for a tour of its purpose-built HQ in Newcastle upon Tyne. QuantuMDx has developed Q-POC™ a revolutionary 30 minute PCR diagnostics device,...